Skip to content

HQY · NASDAQ

HealthEquity (HQY) Stock Price & Fundamentals

$597.27−0.10%−$0.57End-of-day price as of Oct 9, 2026

HealthEquity (HQY) closed at $597.27 on Oct 9, 2026, down 0.10% from the previous close of $597.84.

Share price, past year

1Y +9.55%

52-week range $537.27 – $647.18. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$597.27
Sep 30, 2026$598.76
Aug 31, 2026$560.36
Jul 31, 2026$557.26
Jun 30, 2026$548.50
May 29, 2026$581.91
Apr 30, 2026$618.33
Mar 31, 2026$628.11
Feb 27, 2026$613.05
Jan 30, 2026$629.72
Dec 31, 2025$590.95
Nov 28, 2025$570.52
Oct 31, 2025$547.18

Key statistics

Market cap
$49.52B
P/E (TTM)
215.6
EPS (TTM)
$2.77
Revenue (TTM)
$1.36B
Net income (TTM)
$236.49M
Shares outstanding
82.9M
Dividend yield
—
52-week range
$537.27 – $647.18

HealthEquity's market cap is $49.52B, based on a share price of $597.27 and 82.9M shares outstanding as of Jul 31, 2026.

Financials

HealthEquity reported revenue of $1.31B for fiscal 2026, up 9.47% from fiscal 2025.

HealthEquity earned net income of $215.20M in fiscal 2026, a net margin of 16.4%.

Fiscal 2026 revenue was the highest in the 10 years shown.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Annual revenue by fiscal year; the table below lists the values.
HealthEquity annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2026ended Jan 31, 2026$1.31B+9.5%$215.20M16.4%$2.46$455.13M
FY2025ended Jan 31, 2025$1.20B+20.0%$96.70M8.1%$1.09$337.77M
FY2024ended Jan 31, 2024$999.59M+16.0%$55.71M5.6%$0.64$241.13M
FY2023ended Jan 31, 2023$861.75M+13.9%−$26.14M−3.0%−$0.31$147.28M
FY2022ended Jan 31, 2022$756.56M+3.1%−$44.29M−5.9%−$0.53$132.09M
FY2021ended Jan 31, 2021$733.57M+37.9%$8.83M1.2%$0.12$168.53M
FY2020ended Jan 31, 2020$531.99M+85.2%$39.66M7.5%$0.58$97.72M
FY2019ended Jan 31, 2019$287.24M+25.2%$73.90M25.7%$1.17$109.55M
FY2018ended Jan 31, 2018$229.53M+28.7%$47.36M20.6%$0.77$76.24M
FY2017ended Jan 31, 2017$178.37M—$26.38M14.8%$0.44$41.95M
HealthEquity quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2027ended Jul 31, 2026$350.73M$65.64M$0.78
Q1 FY2027ended Apr 30, 2026$354.64M$69.42M$0.82
Q4 FY2026ended Jan 31, 2026$334.59M$49.74M$0.58
Q3 FY2026ended Oct 31, 2025$322.16M$51.69M$0.59
Q2 FY2026ended Jul 31, 2025$325.84M$59.85M$0.68
Q1 FY2026ended Apr 30, 2025$330.84M$53.92M$0.61
Q4 FY2025ended Jan 31, 2025$311.82M$26.37M$0.30
Q3 FY2025ended Oct 31, 2024$300.43M$5.70M$0.06

Company profile

Name
HealthEquity, Inc.
Ticker
HQY
Exchange
NASDAQ
Industry (SEC SIC)
Services-Business Services, NEC
Headquarters
15 West Scenic Pointe Drive, Suite 100, Draper, UT 84020
Incorporated in
DE
Fiscal year ends
January
SEC CIK
0001428336

Recent SEC filings

Frequently asked questions

What is HealthEquity's stock price?

HealthEquity (HQY) closed at $597.27 on Oct 9, 2026, down 0.10% from the previous close of $597.84.

What is HealthEquity's market cap?

HealthEquity's market cap is $49.52B, based on a share price of $597.27 and 82.9M shares outstanding as of Jul 31, 2026.

How much revenue does HealthEquity make?

HealthEquity reported revenue of $1.31B for fiscal 2026, up 9.47% from fiscal 2025.

What is HQY's P/E ratio?

HealthEquity's price-to-earnings ratio is 215.6, based on trailing twelve-month diluted EPS of $2.77.

Does HealthEquity pay a dividend?

HealthEquity's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from HealthEquity, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures